The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Interim outcome analysis of a prospective phase I trial of surgical resection with intracavitary hyperthermic cisplatin and gemcitabine for patients with resectable malignant pleural mesothelioma.
William G. Richards
No relevant relationships to disclose
Marcelo C Dasilva
No relevant relationships to disclose
Hannah M. Eisen
No relevant relationships to disclose
Julianne C Barlow
No relevant relationships to disclose
Raphael Bueno
No relevant relationships to disclose
David Sugarbaker
No relevant relationships to disclose